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Candida glabrata is an important human fungal pathogen known to trigger serious infections in immune-compromised individuals.
Its ability to form biofilms, which exhibit high tolerance to antifungal treatments, has been considered as an important virulence
factor. However, the mechanisms involving antifungal resistance in biofilms and the impact of host niche environments on these
processes are still poorly defined. In this study, we performed a whole-transcriptome analysis of C. glabrata biofilm cells exposed to
different environmental conditions and constraints in order to identify the molecular pathways involved in fluconazole resistance
and understand how acidic pH niches, associated with the presence of acetic acid, are able to modulate these responses. We show
that fluconazole treatment induces gene expression reprogramming in a carbon source and pH-dependent manner. This is
particularly relevant for a set of genes involved in DNA replication, ergosterol, and ubiquinone biosynthesis. We also provide
additional evidence that the loss of mitochondrial function is associated with fluconazole resistance, independently of the growth
condition. Lastly, we propose that C. glabrata Mge1, a cochaperone involved in iron metabolism and protein import into the
mitochondria, is a key regulator of fluconazole susceptibility during carbon and pH adaptation by reducing the metabolic flux
towards toxic sterol formation. These new findings suggest that different host microenvironments influence directly the physiology
of C. glabrata, with implications on how this pathogen responds to antifungal treatment. Our analyses identify several pathways
that can be targeted and will potentially prove to be useful for developing new antifungals to treat biofilm-based infections.
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INTRODUCTION
Candida spp. are important fungal pathogens known to trigger
serious infections in immune-compromised individuals, affecting
billions of people every year.1 While C. albicans has been
predominantly identified as the most common cause of candidiasis,
infections caused by non-albicans Candida strains such as C. glabrata
have been increasing worldwide.2,3 This trend has coincided with
the prophylactic use of antifungals, which has resulted in increased
drug resistance.4 Moreover, C. glabrata has the ability to adhere and
to form biofilms on both biotic and abiotic surfaces, such as host
tissues and implanted medical devices.5–8 This ability makes these
infections a clinical challenge, as the cells in biofilms are also
intrinsically resistant to conventional antifungal treatments.9
In order to survive and successfully proliferate in the different
host niches, C. glabrata must rapidly adapt to a diverse range of
environmental stresses, such as temperature, pH fluctuations, and
nutrient availability. Some of these niches are complex, dynamic
and frequently limited in the content of carbon sources available.
To survive in such environments, these pathogens have to control
the expression of key metabolic functions.10–12 For instance,
during gastrointestinal and vaginal colonization, where glucose
concentration is low, alternative carbon sources such as acetate or
lactate are particularly abundant13,14 and may support the growth
and the proliferation of C. glabrata cells. Interestingly, low-glucose
environments were found to induce the formation of C. glabrata
biofilms and confer resistance to antifungal treatment.15 This
behavior suggests that this pathogen has the capacity to adjust its
lifestyle in accordance to nutrient availability and determine the
outcome of the next phase: either to continue as part of a biofilm
population or disperse to find new colonization sites. However,
little is known about the physiological effect of acidic environ-
ments, containing alternative non-fermentable carbon sources
such as acetate, on the antifungal treatment of C. glabrata
biofilms. Our group has previously demonstrated that C. glabrata
cells were more susceptible to fluconazole and better phagocy-
tosed and killed by macrophages, when exposed to both glucose
and to physiological concentrations of acetate.16 Growth in the
presence of this substrate also affected the ability of these cells to
form biofilms.16 Although several putative acetate transporters
and channels were identified to be involved in the response to
acetate and fluconazole, in both planktonic and biofilm cells, the
exact molecular mechanisms underlying fluconazole resistance in
biofilms under acidic conditions are still unclear. In this work, the
specific transcriptomic responses of C. glabrata biofilm cells to
fluconazole, when grown in the presence of glucose or glucose
and acetate, were evaluated by RNA sequencing. This allowed us
to decipher the differentially expressed genes and potential
mechanisms developed by biofilms to adapt to these different
physiological environments.
Our data represent a global view of transcriptomic regulation in
C. glabrata biofilms in response to carbon adaptation and
fluconazole resistance. Considering the urgent need to find
adequate and more effective therapeutic approaches to treat
Candida infections, further understanding of the molecular
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mechanisms underlying biofilm formation and antifungal resis-
tance could lead to the development of novel inhibitors to control
the dissemination of these pathogens.
RESULTS
Transcriptional responses of C. glabrata biofilm cells to fluconazole
are modulated by the presence of acetate
C. glabrata biofilms are frequently grown on artificial media
conditions that do not mimic physiological environments, leaving
the effects of important alternative metabolites largely unexplored.
In order to understand the impact of both acidic and acetate-
enriched environments in response to fluconazole treatment, we
evaluated the whole transcriptome of C. glabrata biofilm cells by
RNA sequencing. Biofilms were developed for 48 h in RPMI media
(with low-glucose concentration, 0.2%), either supplemented or not
with 0.5% acetate, and in the presence and absence of fluconazole.
This resulted in a total of four different conditions. The total RNA was
extracted for 12 independent samples, corresponding to four
conditions and three biological replicates. Illumina whole-
transcriptome sequencing produced around 1.6 × 107 (±1.4 × 106)
reads per sample, which resulted approximately in 98% overall
alignment rate. We then performed pair-wise comparisons between
conditions to investigate transcriptional responses to fluconazole
treatment, either when biofilms were grown in the presence of
acetate (RPMI+ acetate) or only in glucose (RPMI).
Figure 1a shows a heatmap depicting the gene regulation of C.
glabrata biofilms in response to both conditions. The adaptation
of biofilm cells to the shift from RPMI to RPMI supplemented with
acetate, when treated with fluconazole, was accompanied by
extensive changes in gene expression. The data show that the
transcriptional response of C. glabrata biofilm cells to fluconazole
is clearly modulated by the presence of acetate (Fig. 1). For both
comparisons, we obtained lists of genes significantly up- and
downregulated and analyzed those displaying at least twofold
regulation (Fig. 1b). We also performed a global functional analysis
on the identified genes in order to find significantly enriched GO
biological process terms and better understand the biological
mechanisms associated with them.
The transcription of genes involved in DNA replication, ergosterol,
and ubiquinone biosynthesis is modulated by the presence of
acetate in response to fluconazole treatment
In order to characterize the transcriptional responses to flucona-
zole of C. glabrata biofilms grown in the presence of acetate, we
compared the transcript profiles of samples grown in RPMI media
supplemented with acetate and fluconazole, with those grown
just in RPMI supplemented with acetate. Upregulated genes were
significantly enriched in biological categories such as “DNA
replication initiation” (CgMCM6 and CgMCM7), “ergosterol biosyn-
thetic process” (CgERG9 and CgERG11) and “ubiquinone biosyn-
thetic process” (CgCAT5, CgCOQ6, and CgCOQ9; Fig. 2). The
overexpression of both Mcm6p and Mcm7p, which are associated
with the MCM complex that initiates and regulates DNA
replication,17 may be indicative of increased cell proliferation that
ultimately may lead to chromosomal instability. This hypothesis is
in agreement with previous observations correlating chromoso-
mal abnormalities in several Candida spp. with exposure to
fluconazole.18 However, this response has never been associated
with the presence of acetate or other non-fermentable carbon
sources during C. glabrata biofilm growth. Considering the
overexpression of ergosterol biosynthetic genes, this is one of
the most common mechanisms of resistance in response to
fluconazole treatment in Candida spp.18 The mechanism of action
of fluconazole involves the inhibition of cytochrome P450 enzyme
lanosterol demethylase, encoded by ERG11.19 This reaction occurs
due to the binding of a free nitrogen atom of the azole ring to an
iron atom within the heme group of the enzyme. This binding
prevents oxygen activation and consequently demethylation of
lanosterol, resulting in the inhibition of ergosterol biosynthesis.
Moreover, Erg9p is also involved in ergosterol biosynthesis but
functions upstream of lanosterol demethylase in the biosynthetic
pathway.20 As ergosterol is an important component of fungal cell
membranes, any impairment in the ergosterol biosynthetic
pathway results in increased cellular permeability leading to the
disruption of cell membranes. Thus, ergosterol overexpression
confers protection against fluconazole treatment by maintaining
sterol homeostasis. Lastly, the three genes encoding proteins
involved in the ubiquinone biosynthesis, Coq6p, Cat5p and
Coq9p, are part of a multi-subunit complex of nine proteins
Fig. 1 Global transcriptional response of C. glabrata biofilm cells to fluconazole treatment when grown in the presence of glucose (RPMI+
fluconazole versus RPMI) or in the presence of both glucose and acetate (RPMI+ acetate+ fluconazole versus RPMI+ acetate).
a Heatmap of all genes differentially expressed (p < 0.05) in the presence versus the absence of fluconazole in both growth conditions. b Venn
diagrams of downregulated (decrease of twofold or lower) and upregulated (greater than twofold) genes in C. glabrata biofilm cells due to
fluconazole treatment in both growth conditions.
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required for ubiquinone biosynthesis.21–24 Ubiquinone, also
known as Coenzyme Q, is an essential component of the electron
transport chain, carrying electrons from Complexes I and II to
Complex III in mitochondria. These proteins are required for
respiratory growth and gluconeogenic gene activation.21–23
Indeed, during growth on non-fermentable carbon sources, such
as acetate, Candida cells induce gluconeogenesis in order to
obtain sugar phosphates for the synthesis of essential cellular
components.25 Collectively, these data suggest that fluconazole
increases chromosome instability, ergosterol biosynthesis and
endogenous respiration in C. glabrata biofilm cells grown in the
presence of acetate (Fig. 2). When grown in the presence of
glucose as sole carbon source, all of these genes were found to be
downregulated (Fig. 3), suggesting that these pathways are
regulated in a carbon source-dependent manner.
Reduction of mitochondrial activity appears to be induced in
response to fluconazole treatment in a manner independent of
carbon source
On the other hand, downregulated genes were significantly
enriched in biological processes related to alterations in mito-
chondrial biogenesis and cell wall organization, as a response to
fluconazole treatment. Genes involved in “protein targeting to
mitochondrion” (CgSAM37, CgMDM12, and CgMMM1) codify a set
of translocases that are part of a Sorting Assembly Machinery
(SAM) complex that mediates the insertion of beta-barrel proteins
into the mitochondrial outer membrane.26–28 The core of this
complex is composed of Sam50p, Sam37p and Sam35p,29–32 but
other proteins such as Mdm12p and Mmm1p are required to
successfully complete this process.33 This transcriptional response
is in accordance with previous transcriptomics and metabolomics
Fig. 2 Transcriptional response of C. glabrata biofilm cells to fluconazole when grown in the presence of acetate. Network visualization of
enriched pathways with the systematic names of C. glabrata (downregulated, left panel; and upregulated, right panel) when grown in the
presence of acetate and fluconazole was performed by ClueGO analysis. The size of the nodes represents the statistical significance of the
terms. The systematic names of C. glabrata genes and respective orthologs in S. cerevisiae associated with each biological process are shown in
red and black, respectively.
Fig. 3 Transcriptional response of C. glabrata biofilm cells to fluconazole, grown in the presence of glucose, as sole carbon source.
Network visualization of enriched pathways with the systematic names of C. glabrata (downregulated, left panel; and upregulated, right panel)
when grown in the presence of glucose and fluconazole was performed by ClueGO analysis. The size of the nodes represents the statistical
significance of the terms. The systematic names of C. glabrata genes and respective orthologs in S. cerevisiae associated with each biological
process are shown in red and black, respectively.
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analysis in C. albicans that suggest a downregulation of
mitochondrial activity as a result of biofilm maturation.34–37 Other
studies have also suggested that the reduction of mitochondrial
activity might be beneficial for biofilm growth, conferring
protection against oxidative damage and promoting prolonged
survival of biofilm cells.38,39 The downregulation of these genes
provides additional evidence that the loss of mitochondrial
functions is associated with fluconazole resistance in C. glabrata.
Other biological categories also found to be downregulated due
to fluconazole treatment include “protein mannosylation”
(CgPMT5 and CgPMT7) and “phosphatidylinositol biosynthetic
process” (CgGPI14 and CgGPI18; Fig. 2). The cell wall glycoproteins
of Candida spp. are modified by N- and O-linked glycosylation and
are attached to the polysaccharides at the cell wall by either
covalent links or glycosylphosphatidylinositol (GPI) anchors.40
The protein O-mannosyltransferases (PMTs) are an evolutionarily
conserved, essential family of proteins that mannosylate distinct
targets in the endoplasmic reticulum.41 In C. albicans, where
these proteins have been well studied, this posttranslational
modification was shown to be involved in morphogenesis,
adhesion and antifungal resistance, suggesting that PMTs can
be studied as potential antifungal targets.42–44 Both Gpi14p and
Gpi18p are also mannosyltransferases but specifically respon-
sible for adding α-1,4-linked and α-1,6-linked mannoses to GPI,
respectively.45–47 As in fungi all of these genes have several
subfamily members that are highly redundant, the effect of their
downregulation is unclear. Interestingly, our data show that
upon fluconazole treatment, biofilm cells grown only in the
presence of glucose exhibit the same transcriptional pattern of
regulation for all categories mentioned above (Figs 2 and 3). We
conclude that these transcriptional responses to fluconazole are
independent of the carbon source.
In glucose-grown biofilm cells, fluconazole treatment induces the
overexpression of genes involved in metabolism, protein folding,
and adhesion
To characterize the transcriptional response of glucose-grown
biofilm cells to fluconazole, we compared the transcript profile of
samples grown in RPMI and fluconazole with those grown in RPMI.
Upregulated genes due to fluconazole treatment were signifi-
cantly enriched in processes related to “primary metabolic
process” (CgAPJ1 and CgHSP104) and aggregation (CgFLO1, also
known as CgEPA1) (Fig. 3). Apj1p is a J protein cochaperone of the
HSP40 family while Hsp104p is a general anti-stress chaperone
that in conjunction with other proteins helps to disassemble
protein aggregates accumulated due to stress.48,49 Heat-shock
proteins (HSPs) are induced by several types of stress and have
broadly protective functions.50 Their expression has been
associated with biofilm formation and drug resistance in
Candida spp., reinforcing their potential as antifungal tar-
gets.48,50,51 Some links between azole resistance and protein
folding functions have also been reported in C. albicans.52,53
CgEPA1 is a GPI-anchored cell wall protein that participates in cell-
cell interactions, allowing adherence to host epithelial tissues.54 In
C. glabrata, Epa1p is the major adhesin mediating adhesion and its
overexpression is associated with resistance to fluconazole.55
Iron acquisition and glycosylation appear to be attenuated by
fluconazole treatment when glucose is present, as sole carbon
source
The transcriptional responses to fluconazole when C. glabrata
biofilm cells were grown in the presence of glucose are associated
with a higher number of differentially regulated genes when
compared with the acetate-dependent responses described
above. Downregulated genes were significantly enriched in
several processes (Fig. 3), including “iron ion transport” (CgFTR1,
CgFTH1, CgCCC2 and CgATX1). Since Ftr1p, Fth1p and Ccc2p are
part of the high-affinity iron uptake system in C. glabrata, and
Atx1p is also involved in iron absorption, downregulation of
these genes may result in perturbed iron homeostasis.56 Given
that iron acts as a cofactor for numerous metalloproteins involved
in several fundamental cellular processes, such as oxygen
transport, respiration, energy metabolism and DNA synthesis
and repair, perturbations in iron homeostasis also have a direct
impact on these processes. This is consistent with some of the
downregulated categories found under the same conditions,
namely, ergosterol biosynthesis. Additionally, genes involved in
“protein glycosylation” (CgWBP1, CgOST1, CgKTR3, CgALG1 and
CgSTT3) were also found to be downregulated in response to
fluconazole (Fig. 2). The cell wall glycoproteins in Candida spp. can
be N- or O-glycosylated. The N-linked glycosylation pathway
requires the action of different glycosyltransferases and comprises
two sequential stages.40,57 The first stage involves the synthesis of
a dolichol-linked glycan precursor and its transfer to a nascent
protein in the rough endoplasmic reticulum. Alg1p is involved in
the synthesis process and Wbp1p, Stt3p, and Ost1p are
transmembrane subunits of the oligosaccharyl transferase com-
plex (OST) that mediate the transference.57 The second stage
includes the N-linked glycan processing and maturation in the
rough endoplasmic reticulum and Golgi. CgKTR3, a member of the
KRE2/MNT1 gene family, may be involved in this last stage but also
in O-linked protein glycosylation.58 A reduction in the levels of
glycosylation will impact the composition of the cell wall and thus
the interaction between the biofilm cells. This is consistent with
data from C. albicans showing that changes in carbon source
affect cell wall architecture, the cell wall proteome and cell wall
organization.59–61 Besides glycosylation, some proteins involved in
the “regulation of phosphorylation” (CgCCL1 and CgVAC14) also
appear to be downregulated in response to fluconazole treatment
(Fig. 3). CgCCL1 positively regulates transcription by Polymerase II
by stimulating phosphorylation of RNA polymerase II C-terminal
domain, with mutants showing increased competitive fitness in
Saccharomyces cerevisiae.62 Vac14p controls the synthesis of
phosphatidylinositol-3,5-biphosphates, impacting several mechan-
isms such as organelle morphology, membrane recycling, and ion
transport.63 Altogether, these biological categories represent a
deregulation in mitochondrion function, cell cycle, cell wall
composition, iron transport, and post-translation modifications,
such as mannosylation, glycosylation, and phosphorylation.
Validation of RNA-seq results with quantitative real-time PCR
(qRT-PCR)
In order to validate the RNA-seq findings, qRT-PCR was performed
on all conditions for six genes that are key members of the most
significant differentially expressed categories found by GO
analysis: CAT5, COQ6, ERG9, ERG11, FTR1, and ATX1 (Fig. 4). All of
these genes were also tested when C. glabrata biofilm cells were
grown in the presence of fluconazole, and when using glucose as
sole carbon source at pH 5.0, to check whether the pH influenced
the changes in gene expression (Supplementary Fig. 1). Signifi-
cantly, the changes in expression observed by RNA-seq were
confirmed by qRT-PCR for all the tested genes. Furthermore, the
changes in expression observed between growth conditions were
independent of the pH (Fig. 4 and Supplementary Fig. 1).
CgMge1 drives fluconazole resistance in acidic and acetate-
enriched environments
C. glabrata is able to colonize and infect acidic and acetate-
enriched anatomical sites, including the gastrointestinal tract and
vagina. We identified a set of genes that are differently regulated
due to fluconazole treatment, when cells are growing in
conditions mimicking those acidic environments. Considering
the overexpression of both CgERG9 and CgERG11 in response to
fluconazole, when Candida biofilm cells are growing in the
R. Alves et al.
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presence of acetate (Fig. 2), we postulated that C. glabrata would
display increased resistance to fluconazole under those condi-
tions. To physiologically validate our transcriptional data, C.
glabrata cells were grown in the presence of fluconazole and/or
doxycycline, an iron chelator reported to have a synergistic effect
with fluconazole.64–66 As a control strain, we used an over-
expression mutant for MGE1 driven by the CgTDH3 promoter in
the 2001HTL strain (Fig. 5).65 This gene encodes a putative
mitochondrial matrix cochaperone, which is a known suppressor
of fluconazole susceptibility in both C. albicans and C. glabrata.65
Since CgMGE1 is upregulated when cells are treated with
fluconazole, under acidic environments (Fig. 5a), we hypothesized
that WT cells would display the same phenotype as MGE1-
overexpressing cells, when grown under similar conditions. We
tested this, and all experiments were performed in triplicate,
showing consistent results among all the independent assays.
Growth conditions were maintained by supplementing RPMI
medium containing 0.2% glucose with the respective stressor and
adjusting the pH to 7.0 or 5.0. This enabled us to compare our
physiological data with the transcriptional outputs.
Phenotypes from control conditions (RPMI pH 7.0) for the MGE1-
overexpressing strain were in agreement with previously pub-
lished data, where CgMGE1 overexpression was shown to play a
role in regulating susceptibility to fluconazole (Fig. 5b).65 As
expected, cells grown under acidic conditions, such as RPMI at pH
5.0 and RPMI at pH 5.0 supplemented with 0.5% acetate, were
more resistant to fluconazole and doxycycline than those grown
only in RPMI at pH 7.0 (Fig. 5b). Interestingly, the synergistic effect
of doxycycline was strongly modulated by pH and the carbon
source, since this effect was abolished under acidic pH, and
moderately restored for the highest concentration of fluconazole
in the presence of acetate (Fig. 5b). As we predicted, both WT and
MGE1-overexpressing cells displayed the same phenotype under
acidic conditions (Fig. 5b). We can conclude from these data that
overexpression of MGE1 under acidic conditions (confirmed both
by RNA-seq and RT-PCR; Fig. 5a) causes a decrease in the
susceptibility of C. glabrata to fluconazole (Fig. 5b). Our data also
highlight the importance of mimicking distinct environmental
niches as local inputs significantly affect the responses of Candida
cells to antifungal treatment.
Fig. 4 Validation by qRT-PCR of genes that were differentially expressed (CAT5, COQ6, ERG9, ERG11, FTR1, and ATX1) in response to
fluconazole in C. glabrata biofilm cells grown with glucose as sole carbon source (RPMI; pH 7.0) or supplemented with acetate (RPMI+
Ace; pH 5.0). Graphs show percentage expression of each gene compared to a housekeeping gene, PGK1. The error bars show standard
deviation. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 were considered statistically significant relative to untreated C. glabrata
biofilm cells.
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Overexpression of CgMGE1 reduces toxic sterol formation
Ergosterol biosynthesis is inhibited in the presence of fluconazole,
favouring the formation of toxic sterols due to the accumulation
of lanosterol (Fig. 7a). Previous work has demonstrated that the
overexpression of CgMGE1 reduces the metabolic flux to toxic
sterol formation.65 Therefore, we performed gas chromatography-
mass spectrometry (GC-MS) analysis to investigate the possible
role of sterols in mediating fluconazole resistance, which is higher
when C. glabrata cells grow in acidic environments and when
MGE1 is upregulated. Sterols were isolated from both WT and
MGE1-overexpressing cells grown in RPMI at pH 7.0, RPMI at pH 5.0
and RPMI at pH 5.0+ 0.5% acetate, in the presence and absence
of fluconazole (Fig. 6b). In addition to sterols such as ergosterol
and lanosterol, we detected other sterols that were less abundant
or could not be identified (Supplementary Fig. 2). This approach
was validated by using an alternative sterol quantitation method
(SQM; Supplementary Fig. 3).67
As can be seen from Fig. 6b, fluconazole treatment leads to
lanosterol accumulation and ergosterol depletion under all the
growth conditions examined. This accumulation favors the
formation of toxic sterols such as 14-methylergosta-8,24(28)-
dien-3β,6α-diol. Remarkably, MGE1-overexpressing cells displayed
reduced levels of this toxic sterol (Fig. 6b). This reduction is
statistically significant only for cells grown under acidic conditions
(p < 0.001 and p < 0.05 for RPMI pH 5.0 and RPMI pH 5.0+ 0.5%
acetate, respectively). Additionally, the balance between ergos-
terol and 14-methylergosta-8,24(28)-dien-3β,6α-diol in these cells
is higher for RPMI at pH 5.0 and RPMI at pH 5.0+ 0.5% acetate
(Fig. 6b). By reducing the metabolic flux towards 14-methyler-
gosta-8,24(28)-dien-3β,6α-diol, other sterol intermediates can
Fig. 5 Fluconazole susceptibility is modulated by pH, carbon source and MGE1 expression in C. glabrata. a Log2 fold-change comparison
of RNA-seq (blue bars) and quantitative RT-PCR (yellow bars) for MGE1 expression in response to fluconazole treatment when C. glabrata cells
are growing either using glucose as sole carbon source (RPMI pH 7.0) or in the presence of acetate (RPMI pH 5.0+ Ace). b Serial dilutions of
wild-type strain (WT; 2001HTL strain transformed with the empty plasmid as a control) and overexpression strain (MGE1; 2001HTL strain
transformed with a plasmid expressing CgMGE1 ORF, together with its terminator, from the CgTDH3 promoter65) were spotted on RPMI
medium containing 0.2% glucose at pH 7.0 or pH 5.0, and/or containing acetate (ace; 0.5% v/v), and/or fluconazole (flu; 8 or 24 µg/mL) and/or
doxycycline (dox; 100 µg/mL). Pictures were taken after 48 h and 72 h of incubation at 37 °C.
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migrate to the plasma membrane and replace the essential
ergosterol functions. Considering that under these conditions, C.
glabrata cells present higher fluconazole resistance (Fig. 5b), these
data present additional evidence for the role of MGE1 in reducing
the levels of toxic sterols and, consequently, decreasing suscept-
ibility to fluconazole.
DISCUSSION
Natural niches of C. glabrata include the human gastrointestinal
and vaginal tracts,68 environments particularly rich in alternative
carbon sources and often limited in the amount of glucose.11 In
order to thrive in these changing nutrient environments, C.
glabrata has evolved sophisticated regulatory mechanisms,
including major metabolic changes that have been associated
with virulence and, in particular, biofilm formation.15,16,69 Once
established, Candida biofilms are very difficult to eradicate due to
their intrinsic tolerance to antifungals. In fact, azole resistance
among Candida species, especially C. glabrata, is currently one
of the greatest clinical challenges.2,4,7 Here, we investigated the
effect of different carbon sources on fluconazole-treated C.
glabrata biofilms by using a RNA-seq approach. For that, biofilms
were grown in the presence of low glucose or low glucose plus
acetate, a non-fermentable carbon source frequently found in
several host niches.14,70 The differentially regulated genes
identified in both growth conditions allowed us to decipher the
potential molecular mechanisms associated with carbon adapta-
tion and fluconazole resistance. Indeed, since most of the genes
are still uncharacterized in C. glabrata, their function was
predicted based on their orthologs in the phylogenetically closely
related yeast S. cerevisiae.
Depending on the growth condition, some genes were found to
be differently regulated in response to fluconazole. These included
genes encoding proteins involved in DNA replication,
mitochondrial function, and ergosterol biosynthesis (Figs 2 and
3). While this observation could be anticipated for the genes
involved in DNA replication and mitochondrial function, as
metabolism is finely coordinated with cell growth, chromosome
replication and cell division, it was quite surprising to find that the
carbon source affects the degree to which fluconazole induces
ergosterol-related genes. As sterol biosynthesis requires heme, we
hypothesize that the expression of these genes is also dependent
on the status of iron acquisition in the cells. Indeed, the expression
profile of iron-related genes is finely tuned with those involved in
the expression of ergosterol (Figs 2–4). Curiously, even with all of
these impairments, C. glabrata cells from biofilms still survive
under high concentrations of fluconazole.16 In fact, it was already
shown that deprivation of iron does not seem to affect the ability
of cells to form biofilms in C. albicans.71 Moreover, the lack of iron
enhances membrane fluidity and drug diffusion in C. glabrata
planktonic cells,66 consistent with the impairment in ergosterol
biosynthesis. On the other hand, our analyses provided additional
evidence that the loss of mitochondrial function is associated with
fluconazole resistance, independently of the growth condition.
Additionally, while physiologically validating our transcriptional
outputs, we realized that C. glabrata Mge1, a cochaperone
involved in iron metabolism and protein import into the
mitochondria, might influence fluconazole susceptibility during
carbon and pH adaptation. We confirmed this experimentally (Fig.
6), thereby reinforcing the role of CgMGE1 in mediating
fluconazole resistance by reducing toxic sterol formation.65
In this study, we did not observe statistically significant
deregulations regarding several well-known genes involved in
fluconazole resistance in planktonic C. glabrata cells. These include
the induction of efflux pumps, encoded by the ABC-transporter
genes, such as CgCDR1, CgCDR2 (also known as CgPDH1), and
CgSNQ2, which are regulated mainly by the transcription factor
CgPDR1.2 Our data suggest that their expression levels differ
Fig. 6 MGE1 overexpression modulates the aberrant flux of sterols following fluconazole treatment. a Schematic representation of sterol
biosynthetic pathways. Erg11 is the primary target of fluconazole. Red names represent toxic fungistatic sterols. b CgMGE1 overexpression
reduces toxic sterol formation. Cells were grown in RPMI medium containing 0.2% glucose at pH 7.0, or pH 5.0, and/or containing 0.5%
acetate, in the presence or absence of fluconazole for 24 h. Sterol levels were determined by GC-MS and are displayed for lanosterol,
ergosterol, and 14-methylergosta-8,24(28)-dien-3β,6α-diol. The values were calculated relative to the internal standard (ITS; cholestane). The
error bars show standard error of the mean. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 were considered statistically significant relative to
C. glabrata WT cells. Gray dotted grid lines in each condition represent the mean obtained for ergosterol content for the same MGE1-
overexpressing cells.
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markedly between biofilms and planktonic cells (Supplementary
Fig. 4). This observation is consistent with previous work done in
C. albicans.72 Mutants knocked out in these genes were
hypersusceptible to fluconazole when growing as planktonic
cells, but not when growing as biofilms.72 This may reflect altered
responses due to the characteristics intrinsically related with the
biofilm lifestyle, such as growth on a surface, the presence of a
protective extracellular matrix, differences in nutrient require-
ments and metabolism, and/or quorum-sensing mechanisms.73
Based on the data presented here, we propose a model in which
resistance to fluconazole in C. glabrata biofilms is modulated by
the available carbon source and pH (Fig. 7). This is particularly
relevant for a set of genes involved in DNA replication, ergosterol,
and ubiquinone biosynthesis. When grown in the presence of
glucose, responses to fluconazole treatment are extensive and
involve the deregulation of several cellular functions (Fig. 7a). On
the other hand, when acetate is present in the growth media,
fluconazole treatment impacts mainly chromosome instability, cell
wall integrity, and mitochondrial function (Fig. 7b).
Our analyses provide a global overview of the genetic and
regulatory mechanisms developed by this microorganism in
response to antifungal treatment, and highlights the impact of
acidic environments on these processes. These alterations at
transcriptional level following fluconazole treatment, either in the
presence of glucose or acetate, enhance the robustness of C.
glabrata biofilms to tolerate this antifungal. Our data reveal new
roles of uncharacterized C. glabrata genes and provide more
knowledge towards the identification of new potential antifungal
targets. Understanding the mechanisms behind fluconazole
resistance may improve and facilitate the development of new
antifungal compounds to treat Candida infections.
METHODS
Media, strains, and growth conditions
Biofilm experiments were done using Candida glabrata ATCC 2001. This
strain was subcultured on Sabouraud dextrose agar (SDA, Difco, Le Pont de
Claix, France) medium at 37 °C for 24 h and then inoculated in Sabouraud
dextrose broth (SDB; Difco) medium at 37 °C for 20–24 h while shaking at
120 rpm. Yeast cells were harvested by centrifugation after the incubation
period (6500 × g, for 10min at 4 °C), washed twice in phosphate buffered
saline (PBS; pH 7.0, 0.1M), and the cellular concentration was adjusted to 1 ×
107 cells/mL using an improved Neubauer chamber. All experimental assays
were carried out in filter-sterilized RPMI 1640 medium with L-glutamine
(Sigma, R6504) and buffered with 0.165Mmorpholinepropanesulfonic acid at
Fig. 7 Schematic overview of the transcriptional responses of C. glabrata biofilms to fluconazole. Differentially expressed genes upon
fluconazole treatment when cells are grown in the presence of a glucose and acetate or b glucose.
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pH 7.0 or 5.0. Fluconazole (Sigma; F8929), doxycycline (Sigma, D9891) and
acetic acid (Sigma, A6283) were added to the medium at concentrations of 8
or 24 µg/mL, 100 µg/mL, and 0.5% (v/v), respectively (unless otherwise
stated). Depending on the assay, autoclave-sterilized and precooled agar was
added to the medium. Cell cultures containing fluconazole or doxycycline
were always kept in the dark. Detailed information about MGE1-over-
expressing strain and respective wild-type control can be found in Demuyser
et al.65
Biofilm development
Candida biofilms were developed on 24-well polystyrene plates (Orange
Scientific, Braine-l’Alleud, Belgium; 12 wells for each condition) containing
1mL of C. glabrata cell suspension (1 × 107 cells/mL in RPMI 1640) per well.
The plates were then incubated at 37 °C under agitation at 120 rpm. After
24 h, 500 μL of media in each well was removed and an equal volume of
fresh media was added according to each condition (RPMI at pH
5.0 supplemented with 0.5 % (v/v) acetic acid; RPMI at pH 5.0 supple-
mented with 0.5% (v/v) acetic acid and 1250 µg/mL fluconazole; RPMI at
pH 7.0; and RPMI at pH 7.0 supplemented with 1250 µg/mL fluconazole).
The concentration of fluconazole was selected according to previous
studies with C. glabrata biofilms.16 Plates were then incubated for
additional 24 h at 37 °C under agitation at 120 rpm.
RNA isolation
Following Candida biofilm development, each well was gently washed
with 1mL of PBS to remove non-adherent cells. Then biofilms were
scraped from the plates with 500 µL of PBS per well, sonicated for 30 s at
30% amplitude (Ultrasonic Processor, Cole-Parmer, IL, USA) in order to
separate cells from matrix74 and then harvested by centrifugation at
8000 × g for 10min at 4 °C. Cells drops were flash frozen in liquid nitrogen
and total RNA was isolated from frozen cell pellets using the RiboPure
Yeast kit (Ambion, Life Technologies, USA), according to manufacturer’s
instructions. All samples were treated with Turbo DNAse (Ambion) to
remove residual DNA, according to manufacturer’s instructions. Total RNA
yield was quantified using the Nanodrop 1000 (Thermo Scientific) and RNA
quality (RNA Integrity Number (RIN) values ≥ 7.0) assessed on a Bioanalyzer
2100 (Agilent Technologies).
RNA sequencing
Library preparation and RNA sequencing were performed at Edinburgh
Genomics (Scotland, UK). All samples were prepared in biological triplicates
and subject to removal of ribosomal RNA before complementary DNA
(cDNA) library generation. From these libraries, 50 base-paired-end
sequence reads were produced with Illumina Hiseq 2000. The raw
sequence data in fastq format as well as the processed data have been
deposited in NCBI’s Gene Expression Omnibus75 and are accessible
through GEO Series accession number GSE121074.
Data analysis
Raw fastq files were successively processed in the following order through
Fastqc (v. 10.1), Trimgalore (v. 3.1), Samtools (v. 1.19), Bowtie2 (v. 2.1), and
Htseq (v. 5.4). Genome alignment was conducted against the
C_glabrata_CBS138_version_s02-m04-r05_chromosomes.fasta file provided
by Candida Genome Database.76 Aligned data were quality-controlled via the
Partek Genomics Suite software (v. 6.6), according to the manufacturer’s
instructions. Gene expression analysis was performed using Partek Genomics
Suite software using a log2 data transformation as the Partek recommended
default. Gene ontology (GO) term analysis was performed in parallel through
the Candida Genome Database GO Term Finder and the Cytoscape (v. 3) Clue
GO plugin.77 Network construction was performed with Cytoscape V.3
freeware,78 venn diagrams through Venny online freeware (v. 2.0.2) and
heatmaps with TM4 MultiExperiment Viewer (MeV, v. 4.9). A statistical
comparison among GO term enrichment percentages was performed with
GraphPad Prism (v. 6) using the Student’s t-test for two-tailed data. Data
represent three independent biological replicates for each condition.
Quantitative real-time PCR (qPCR)
Real-Time quantitative PCR of cDNA samples was carried out in a CF X96
Real-Time PCR System from Bio-Rad Laboratories using Power SYBR® Green
PCR Master Mix (Applied Biosystems, CA, USA), according to manufac-
turer’s instructions. The High-Capacity cDNA Reverse Transcription Kit
(Invitrogen, CA, USA) was used to synthesize the cDNA in a 20 µL reaction
containing 1 µg of total RNA, according to the manufacturer’s instructions.
The primers used to amplify the selected genes and the thermocycling
conditions are described in Supplementary Table 1. The reaction mixture
was set up in a total volume of 20 μL using 10 μL of SYBR Green PCR Master
Mix, 0.3 μM of each primer and 4 μL of each synthesized cDNA sample
(diluted 1:20) and nuclease-free water. A negative control without
template was conducted for each gene in each PCR run, and a control
for DNA contamination was implemented by using the purified RNA
samples as templates. The housekeeping gene, PGK179 was used to
normalize the gene expression. Experiments were performed in triplicate
for three independent biological samples. Statistical analysis were
performed using two-way ANOVA with Bonferroni correction.
Sterol measurement
Sterols were extracted according to the method described in Morio et al.80
with a few adaptations. In summary, cells were grown for 24 h in RPMI
medium, with or without 24 μg/mL fluconazole. The cells were collected,
resuspended in saponification medium, and subjected to vortex mixing.
The samples were incubated for 1 h at 80 °C, after which 1mL of water and
4mL of hexane were added. After mixing, the two layers were allowed to
separate. For spectrophotometrical analysis, UV-transmittable 96-well
microtiter plates (Costar Corning) were used to allow measurement of
the OD281 and OD230. A formula from Arthington-Skaggs et al.
67 was used
to measure the percentages of ergosterol (corrected for cellular wet weight
and resuspension volume). For GC-MS analysis, the sterols were extracted
twice with hexane, which was then evaporated by vacuum centrifugation.
The sterols were resuspended in 100 μL silylating mixture (Sigma) and
incubated at room temperature for 30min. Finally, a corrected cellular wet
weight resuspension volume of hexane was added and the samples were
immediately stored at −20 °C for later analysis by GC-MS. One microliter of
the sample was injected into a gas chromatograph-mass spectrometer
(Shimadzu QP2010 Ultra Plus) equipped with an HP-5ms nonpolar column
(Agilent) (30m in length, 0.25-mm inner diameter [id.]; 0.25-µm thin layer).
Helium was used as carrier gas with a flow rate of 1.4 mL/min. Injection was
carried out at 250 °C in split mode after 1 min and with a ratio of 1:10. The
temperature was first held at 50 °C for 1 min and then allowed to rise to
260 °C at a rate of 50 °C/min, followed by a second ramp of 2 °C/min until
325 °C was reached; that temperature was maintained for 3 min. The mass
detector was operated in scan mode (50 to 600 atomic mass units [amu]),
using electron impact ionization (70 eV). The temperatures of the interface
and detector were 290 and 250 °C, respectively. A mix of linear n-alkanes
(from C8 to C40) was injected to serve as external retention index markers.
Sterols were identified by their retention time relative to the internal
standard (cholestane) and specific mass spectrometric patterns using
AMDIS version 2.71. The deconvoluted spectra were matched to GC-MS
libraries described in Müller et al.81 and NIST/EPA/NIH version 2011.
Analysis was performed by integration over the base ion of each sterol,
and abundance was calculated relative to the internal standard, comparing
the relative peak areas of the compounds across treatments using two-way
ANOVA with Bonferroni correction.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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